Stevanato Group(US:STVN) Financial Modeling Prep·2026-03-05 23:16Company Overview - Stevanato Group S.p.A. is a leading entity in the pharmaceutical and healthcare industry, known for its production of glass containers and integrated systems for drug delivery, with a strong global presence and innovative solutions [1] Financial Performance - The recent Q4 2025 earnings call provided insights into Stevanato Group's financial performance, discussing revenue, profit margins, and future outlook, which are crucial for understanding the company's operational strategies and market conditions [3] - Stevanato Group's market capitalization stands at approximately $4.37 billion, with a trading volume of 388,631 shares, indicating significant stock volatility over the past year [4][5] Stock Performance - Paul Knight from KeyBanc set a price target of $32 for STVN, suggesting a potential price increase of approximately 99.88%, while the stock is currently priced at $15.99, reflecting a decrease of 8.63% today [2][5] - Over the past year, the stock has reached a high of $28 and a low of $13.91, indicating the potential for significant price movements [4]